Loading stock data…
MBOT
$2.10+0.01 (+0.48%)
Market ClosedLast close May 1
Microbot Medical Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Microbot Medical Inc. in the Healthcare sector is trading at $2.10. The stock is currently near its 52-week low of $1.60, remaining 17.6% below its 200-day moving average. Technical signals show neutral RSI of 32 and bearish MACD signal, explaining why MBOT maintains its current current market pressure. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 32) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$2.10
Potential Upside
5%
Whystock Fair Value$2.21
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a cathe...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$149.09M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.19
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-18.09%
Volume
Today's trading volume
1.05M
Recent News
Will DXCM's G7 Uptake Continue to Drive Top-line Growth in Q1?
DexCom's Q1 results may see strong growth from G7 uptake and CGM demand, but pricing mix and rising investments could weigh on margins.
Microbot Medical Begins Full U.S. Launch of LIBERTY System
MBOT moves to full U.S. launch of its LIBERTY robotic system after strong hospital adoption, boosting momentum for faster market uptake and sales growth.
Here's Why We're Not Too Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. By way of example, Microbot Medical...
Sector Update: Health Care Stocks Softer Late Afternoon
Health care stocks were lower late Wednesday afternoon, with the NYSE Health Care Index easing 0.1%
Sector Update: Health Care Stocks Mixed in Afternoon Trading
Health care stocks were mixed Wednesday afternoon, with the NYSE Health Care Index up 0.1% and the H